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Objective: To test the hypothesis that nasal endotracheal tubes are more secure 
and associated with fewer complications than oral endotracheal tubes. This 
involves establishing the incidence of specific endotracheal tube complications 
between cardiac patients who are intubated via the oral and nasal route. In 
addition, a secondary objective is to identify specific risk groups that could benefit 
from a change in practice or implementation of guidelines.   
Design: A retrospective chart review of 100 patients who were admitted to the 
Pediatric Cardiac Intensive Care Unit with an endotracheal tube in place was 
performed. Patients involved in this preliminary study were selected from a larger 
patient population admitted to Boston Children’s Hospital during the fiscal year of 
2011 (October 1, 2010 through September 30, 2011). Variables that were 
collected include: gender, type of mechanical ventilation, reasons for admission, 
RACHS-1 scores, outcome of respiratory support, age and weight of patients, 
duration of ventilation, reason for ventilation, cuffed vs. un-cuffed ETT, size of 
 v 
ETT, initial tube depth, route of intubation, location of intubation, duration of 
ventilation, CICU and hospital length of stay, and inotropic scores. The specific 
complications that were analyzed were: inadequate ETT positioning or securing 
with the need for re-adjustment, accidental or unplanned extubations, device 
related pressure ulcers and skin breakdown, and feeding problems related to 
dysphagia. The Z-test was used to determine if the difference in rate of 
complications between cardiac patients who were orally intubated and cardiac 
patients who were nasally intubated was statistically significant. The Fisher’s 
Exact test was also used to confirm the z-test since the sample size was 
relatively small. Finally, a multi-variable regression with select variables was 
performed to observe possible confounding factors. The Fisher’s Exact test and 
Mann-Whitney U-test were used to determine which covariates would be 
included in the multivariable regression.     
Results: There were 67 patients in the oral ETT group and 33 patients in the 
nasal ETT group. 17 out of 67 or 25% of the oral ETT patients experienced 
complications, whereas 6 out of 33 or 18% of the nasal ETT patients experienced 
complications. The difference between the two proportions was 7%, and the Z-
test revealed the p value to be 0.2107 and 0.4214 for the two-tail test. Both p 
values were > 0.05; therefore, the null hypothesis could not be rejected. The 
Fisher’s Exact test revealed that the 2X2 contingency table, made from the two 
treatment groups and outcomes, had a p value of 0.4621. This also confirmed 
that the null hypothesis could not be rejected. Overall, the incidence rate of any 
 vi 
complication was 23 out of 100 or 23%. Mann-Whitney U tests and Fisher’s 
Exact tests were performed on critical variables including gender, age, weight, 
RACHS-1 score, total CMV hours, maximum inotropic score, and cuffed vs 
uncuffed ETT. Results showed that only four of those variables – age, weight, 
CMV hours, and inotropic score – had p values < 0.05. These four variables, 
along with the route of intubation, were used as the covariates for the multivariate 
logistic regression with respect to ETT complications as the outcome. The 
regression revealed that only higher inotropic scores and age could be 
associated with a higher risk for complications. Inotropic score had a p value of 
0.009 and age had a p value of 0.025; both were < 0.05. Weight, CMV hours, 
and ETT route had p values of 0.92, 0.93, 0.77, respectively.   
Conclusions: Our hypothesis that cardiac patients with nasal ETT’s have 
statistically lower complication rates than cardiac patients with oral ETT’s could 
not be proven to be correct. The observed proportion difference between the two 
groups may be due to chance. However, our results revealed several other 
variables that may be associated with increased risks of ETT complications. A 
continuation of this preliminary study is being performed to include a much larger 
group of patients in order to gain more conclusive data on both the oral and nasal 
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Patients in the Pediatric Cardiac Intensive Care Unit 
The patients selected for this retrospective study were mainly diagnosed with 
and treated for various types of heart diseases. Patients with congenital and 
acquired heart diseases require complex surgeries or procedures and 
appropriate intensive care towards recovery (Jenkins, Gauvreau, Newburger, 
Spray, Moller, & Iezzoni, 2002; Varma, 2011). At Boston Children’s Hospital, this 
specific patient population receives specialized support in the pediatric cardiac 
intensive care unit. While most of the patients are children, there are also 
occasionally adults and older patients admitted to the pediatric CICU at BCH for 
continual and long-term treatment of congenital heart diseases (Boston 
Children’s Hospital, 2011).  
The main role of this CICU is to maintain respiratory and cardiovascular 
physiology, neurological activity, and function of other organ systems in cardiac 
patients in order to improve their outcomes (Boston Children’s Hospital, 2011). 
With respect to this support, one important device used in the CICU (and OR) is 
artificial ventilation (Boston Children’s Hospital, 2011). Artificial ventilation, or 
mechanical ventilation, delivers high levels of oxygen – in adjustable amounts 
and frequencies - to patients who are otherwise unable to breathe on their own 
due to illness or general anesthesia (American Thoracic Society, 2005; National 
Heart Lung and Blood Institute, 2011). These devices can also help patients 
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exhale CO2 and prevent their alveoli from collapsing by providing positive 
pressure ventilation via PEEP in their lungs (American Thoracic Society, 2005). 
In conjunction with other instruments such as the blood pressure cuff and pulse 
oximeter, artificial ventilation also helps physicians monitor patients’ vital signs 
regarding cardiovascular and respiratory physiology.  
Although there are various types of artificial ventilation for different 
conditions, they all need to be connected to the patient’s airway, mainly through 
an endotracheal tube (Boston Children’s Hospital, 2011; Schiffman, & Stoppler, 
2007). Thus, the endotracheal tube serves as an essential tool that maintains a 
patent airway, and allows patients to breathe artificially in the OR and during 
postoperative recovery (Schiffman, & Stoppler, 2007). Additionally, the ETT 
allows physicians to administer medications and anesthesia, view the upper 
respiratory tract, and suction fluids and mucus when necessary (American 
Thoracic Society, 2005; MedlinePlus, 2013). The setup of the ventilator and ETT 
is shown in figure 1. 
With regards to this study, patients with congenital heart defects or diseases 
have several different indications for endotracheal intubation (Chang, Hanley, 
Wernovsky, & Wessel, 1998). Some patients may arrive to BCH already 
intubated in order to prevent respiratory complications during transport between 
facilities; others may require airway protection and positive pressure ventilation 
after cardiorespiratory arrest, pulmonary edema (to decrease the workload on the 
lungs), or left ventricular dysfunction (Chang et al., 1998). Still, many patients 
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who require surgeries or procedures undergo general anesthesia, which may 
disrupt regular breathing; they are intubated in the OR or CATH LAB and then 
slowly weaned off the artificial ventilator as they recover in the CICU (American 
Thoracic Society, 2005; National Heart Lung and Blood Institute, 2011; 





Figure 1: Patient on a Ventilator. This picture depicts how the artificial 
ventilator is connected to the secured endotracheal tube and shows the airflow 
that occurs. Although this is an adult patient, the general setup applies to 
pediatric patients as well. (Figure downloaded from “National Heart Lung and 
Blood Institute, 2011”).    
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The Process of Endotracheal Intubation 
In order to guide the endotracheal tube to the correct position, physicians 
usually follow a general procedure that involves the use of a laryngoscope. The 
laryngoscope serves to open up the passageway to the vocal cords and provide 
a better view for ETT insertion (Kabrhel, Thomsen, Setnik, & Walls, 2007; 
Schiffman, & Stoppler, 2007). Upon administration of general anesthesia, the 
physician can open the patient’s mouth and use the laryngoscope to push back 
the tongue and advance the blade (position depending on the type of blade) 
towards the epiglottis (Kabhrel et al., 2007). Once the epiglottis is lifted, the vocal 
cords should be exposed, allowing the physician to insert the ETT through and 
into the patient’s trachea (Kabhrel et al., 2007). While this is the basic outline of 
the procedure, there are various details including: angle of blade, entry point of 
ETT, adjustments to head/neck position, landmarks and signs, etc., which 
influence proper intubation (Kabhrel et al., 2007). Proper intubation is shown in 
figure 2. The critical steps of this process, that may influence complications both 
during and after intubation, include selection of the ETT type and size, 
positioning or depth of the ETT, and the route of intubation itself (nasal vs oral).        
 Once the ETT is inserted, there are multiple methods of confirmation to 
ensure proper ventilation to the lungs. Using an end-tidal carbon dioxide detector 
on the ETT allows the physician to observe if CO2 is being exhaled from the 
patient, which indicates that normal gas exchange is occurring in the lungs 
(Kabhrel et al., 2007).  A second method of confirmation is to listen to the 
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patient’s stomach and lungs using a stethoscope; breath sounds should be 
bilateral and equal and not present in the stomach (Kabhrel et al., 2007). Finally, 
a chest x-ray can be used to view the lungs and also confirm that the ETT is 
positioned above the carina – by observing the radio-opaque line (figure 3) along 





Figure 2: Endotracheal Intubation. This figure illustrates how a laryngoscope is 
used to place an oral ETT into the upper airway of the patient. Note that the 





Choosing the proper ETT size and type 
Finding the right endotracheal tube for each pediatric patient is a critical step 
in ensuring proper ventilation. However, this is a difficult task due to the small 
size and sensitivity of the pediatric airway (Davis et al., 1998). If the tube were 
too large, it could cause swelling and damage to the vocal cords and eventually 
tracheal stenosis (Davis et al., 1998). Furthermore, unlike the adult airway, the 
pediatric airway significantly decreases in cross sectional area proportionally to 
edema and swelling (Davis et al., 1998). This would constrict the airway and limit 
the amount of air ventilation. If the tube were too small, then it would create a 
leak around the tube and cause improper ventilation (Davis et al., 1998). 
Endotracheal tubes are assigned numbers such as 3.0, 4.5, and 7.0, which 
indicate the internal diameter of the tube in millimeters (Kabrhel et al., 2007). In 
order to determine the proper size for the ETT, physicians commonly use the 
age-based (AB) formula, which is: (the age of the patient + 16) divided by four 
(Davis et al., 1998). However, there are many other methods of choosing the 
right ETT size that take different variables into account when the age is not 
available. Some examples include: the Broselow pediatric resuscitation tape 
method using body length, the fifth finger diameter method, and the fifth fingernail 
width method (Davis et al., 1998; King, Baker, Braitman, Seidl-Friedman, & 
Schreiner, 1993). Thus, the variability in ETT size selection can influence both 
immediate complications during intubation and delayed complications during 
post-intubation. 
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Along with the ETT size, another factor to consider is whether the ETT is 
cuffed or uncuffed. The uncuffed form is the original design that pediatric 
anesthesiologists first used and still continue to use on a wide basis (Weber, 
Salvi, Orliaguet, & Wolf, 2009). In fact, until the 2000’s, uncuffed ETT’s were 
always used for intubation and anesthesia administration in patients under the 
age of 8 (Weber et al., 2009). The cuff was introduced in order to make positive 
pressure ventilation much more effective with the ETT (Spiegel, 2010). 
Generally, the optimal placement of the cuff would be right under the vocal cords 
(Spiegel, 2010). Figure 3 shows how the cuff is located distal to the double black 
lines on the ETT to ensure that the cuff is positioned correctly. The cuff itself is 
also connected to a separate thin tube running along the ETT with a valve and 
pilot balloon; this allows physicians to adjust the cuff pressure by inserting or 
drawing back air with a syringe (Spiegel, 2010). Figure 4 shows the cuff and pilot 
balloon in place.  
While the selection of ETT type depends on each individual case, there are 
several important components that should be considered. First, a cuffed ETT 
requires a smaller diameter within the tube itself because of the extra space 
needed for the cuff (Weber et al., 2009). Second, anesthesiologists need to 
spend more time and energy maintaining the correct cuff pressure (Weber et al., 
2009). If the cuff pressure were too high, it could cause damage to the patient’s 
airway and even stridor (Weber et al., 2009). High pressure could also puncture 
or break the cuff itself and cause major problems in the trachea (Weber et al., 
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2009). If the cuff pressure were too low, then the cuff would fail to secure the 
airway. In addition, external factors such as temperature and muscle relaxation 
keep the cuff pressure from staying constant (Weber et al., 2009). Third, there 
are numerous manufacturers and designs for cuffs, which make it difficult to have 
standard protocols and methods for intubation (Spiegel, 2010; Weber et al., 
2009). 
 Despite these disadvantages, cuffed ETT’s also bring a whole new set of 
benefits to the pediatric patient. The cuff itself provides a better, tighter seal 
between the ETT and the airway (Weber et al., 2009). This allows more efficient 
ventilation, especially for PEEP in patients with low lung compliance (Weber et 
al., 2009). Having a tighter seal also allows anesthesia to be precisely 
administered and leak into the atmosphere less (Weber et al., 2009). Another 
strong benefit of cuffed ETT’s is the increased prevention of gastric aspiration 
due to the tight seal around the airway (Weber et al., 2009). The cuff also helps 
center the ETT in the trachea in order to prevent the distal tip from damaging the 
airway tissues (Spiegel, 2010). Finally, cuffed ETT’s may also reduce the 
incidence of unplanned extubations or multiple intubations, which are part of the 
complications observed in this study (Weber et al., 2009). While uncuffed ETT’s 
require reintubation when adjusting for correct tube diameter, cuffed ETT’s can 
be adjusted by increasing or decreasing cuff pressure to provide a closer fit 
(Weber et al., 2009). Overall, it seems that cuffed tubes may be especially useful 
for pediatric cardiac patients with compromised cardio-respiratory functions and 
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patients undergoing both anesthesia and major surgery as well (Lonnqvist, 
2009). However, it has not been proven that cuffed tubes are less associated 
with ETT complications compared to uncuffed tubes. Examples of commonly 





Figure 3: Endotracheal Tube. Above are two ETT’s; the top one is cuffed while 
the bottom one is uncuffed. Both have connecting points on the far right to 
artificial ventilation. The thin line running down the tube’s length is the radio-
opaque line. The number (size) of the ETT would be written on the left of the 
position markers indicated by numbers and bold lines along the width of the tube. 
The top ETT shows the double black line near the cuffed end as used in 
determining ETT depth. These ETT’s can be used both in the oral or nasal route 
as labeled above. (Figure downloaded from “Intensive Care Coordination and 
Monitoring Unit, 2011”) 
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Depth of the Endotracheal Tube 
Even with the correct size and type of ETT, the position or depth of the 
endotracheal tube in the patient’s airway is an essential factor in the intubation 
process. Since children have much shorter airways than adults, finding the right 
depth of the ETT in pediatric patients is an especially crucial and difficult task for 
physicians (Mariano E.R., Ramamoorthy, C., Chu, L.F., Chen, M., & Hammer, 
G.B., 2005). If the ETT is positioned too high in the trachea, it can increase the 
chance of an unplanned extubation and loss of a secured airway (Mariano et al., 
2005). If the ETT is positioned too low, it may hit the carina or go into one of the 
main bronchi and ventilate only one side of the lungs; this can cause 
pneumothorax, atelectasis (lung collapse), and/or traumatic lung tissue injury 
(Mariano et al., 2005; Schiffman, & Stoppler, 2007). A common method of 
determining the correct placement is using the formula: [(Patient’s age in years / 
2) +12] and using the resulting number as the centimeter mark on the ETT 
(Kabrhel et al., 2007). However, just as there are various methods of size 
selection, there are different methods used by physicians to determine the 
appropriate depth of the ETT. One method involves intentionally intubating a 
patient endobronchially and then pulling back the ETT until bilateral lung sounds 
can be heard; the ETT is pulled back an additional 2 cm and then taped down 
(Mariano et al., 2005). Another method involves advancing the ETT until the 
double black lines near the distal end are aligned with the vocal cords (Mariano 
et al., 2005). However, this method would only work if the ETT used has the 
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double black line design as shown in figure 3. A third alternative method uses 
another formula: three times the millimeter diameter of the ETT (Mariano et al., 
2005). All of these methods are approximations at best; the best way to confirm 
the correct depth is “direct visual verification” using radiography, fluoroscopy, or 
fiberoptic bronchoscopy (Mariano et al., 2005).  
 
Complications that may occur during ETT placement 
While endotracheal intubation is a very common procedure, it still requires 
intensive training and practice because of the associated life-threatening 
complications that may occur (Schiffman, & Stoppler, 2007). Improper placement 
of the ETT into the esophagus can cause inadequate ventilation, which can lead 
to hypoxemia and neurological and cardiovascular damage (Kabrhel et al., 
2007). Undesired ventilation through the esophagus can also cause aspiration of 
stomach contents, leading to pneumonia and acute respiratory distress 
syndrome (Kabrhel et al., 2007; Schiffman, & Stoppler, 2007). Improper 
placement of the ETT into one of the main bronchi can also occur, which can 
damage lung tissue and prevent bilateral ventilation as previously mentioned 
(Mariano et al., 2005; Schiffman, & Stoppler, 2007). In addition, stimulation of the 
pharynx with the ETT can cause “bradycardia, laryngospasm, bronchospasm, 
and apnea” in some patients (Kabrhel et al., 2007). The use of the laryngoscope 
and ETT can also damage the patient’s teeth, lips, vocal cords, and throat if 
inserted improperly or too forcefully (Kabrhel et al., 2007). 
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Complications that may occur during post-intubation 
One of the major complications that are associated with indwelling ETT’s is 
the need for ETT manipulation and adjustment post-intubation. This type of 
complication involves the need to advance or pull back an ETT, and also re-tape 
or re-secure the ETT. This repositioning of the ETT requires additional sedation, 
respiratory staff assistance, and radiological confirmation (Rigini, Boaz, Ezri, 
Evron, Trigub, Jackobashvilli, & Izakson, 2011; Yoo, Kim, Han, & Oh, 2007). The 
ETT size, type, and depth all play an important role in the development of this 
complication.  Even though endotracheal intubation as a procedure has been 
well established, the selection of cuffed vs. uncuffed ETT is still controversial and 
often highly dependent on provider bias (Newth, Rachman, Path, & Hammer, 
2003). In addition, there are different methods available for choosing the proper 
size and depth of endotracheal tubes, based on patient demographics (Davis, 
Barbee, & Ririe, 1998; Hofer, Ganter, Tucci, Klaghofer, & Zollinger, 2002). Thus, 
the variability in ETT selection and insertion, based on physician preference and 
patient condition, may influence the onset of these acute complications. 
Essentially, ETT manipulation is generally an indication that the ETT selection 
was incorrect, the intubation method was flawed, or the ETT became displaced 
due to the patient’s head and neck movements (Kabrhel et al., 2007; Yoo et al., 
2007). If the ETT is not repositioned and secured properly, the patient can 
experience an accidental or unplanned extubation, which is another major 
complication (Silva, & Carvalho, 2010).  
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Unplanned extubation is an undesired and life-threatening event where an 
airway device such as the ETT becomes accidentally displaced and ceases to 
ventilate the patient adequately (Silva, & Carvalho, 2010). Unplanned 
extubations can be caused by inadequate initial positioning of the tube, improper 
securing of the ETT, or movements of the patient’s head and neck (Silva, & 
Carvalho, 2010; Yoo et al., 2007). Unplanned extubations can also occur when 
necessary readjustments of the ETT are not performed (Silva, & Carvalho, 2010). 
This type of complication is particularly more prevalent in pediatric patients since 
children are more susceptible to the discomforts of ETT’s, and they have a much 
shorter trachea than adults (Silva, & Carvalho, 2010). As mentioned previously, 
the type, size, and placement of the ETT can greatly influence the risk of 
unplanned extubation. Furthermore, the wide variety of methods used by 
physicians to secure and/or tape down the ETT may be an important factor in the 
incidence of unplanned extubations (Silva, & Carvalho, 2010). The main 
consequences associated with this specific complication include: the need for 
reintubation or multiple intubations, extended duration of artificial ventilation, and 
longer ICU and hospital stay (Groot, Dekkers, Herold, Jonge, & Arbous, 2011). 
All of these factors may then increase the risk for the other two major 
complications, dysphagia and skin breakdown, and reintroduce the risk of ETT 
adjustment. 
In addition to the risk for potential hypoxia and acute airway injury, ETT’s can 
also be associated with pressure ulcers at the site of insertion after intubation 
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has occurred (Souza, & de Carvalho, 2009; Taylor, Subaiya, & Corsino, 2011; 
Weber, Salvi, Orliaguet, & Wolf, 2009). For patients who are orally intubated, the 
oral ETT can cause skin breakdown on the lips, mouth, gums, and even tongue 
(Zaratkiewicz, Teegardin, & Whitney, 2012). The damage is caused by the 
abrasive contact between soft tissues and the hard plastic surface of the ETT 
(Fletcher, 2012). Furthermore, the duration of contact between mucosal tissue 
and an external surface (the plastic ETT lining) may dictate the severity of the 
skin damage and stage (1-4) of the pressure ulcer (McCord, McElvain, 
Sachdeva, Schwartz, & Jefferson, 2004). While nasal ETT’s are not associated 
with oral pressure ulcers, they may cause nasal tissue breakdown in a similar 
manner (Zaratkiewicz et al., 2012). These complications may be difficult to 
prevent because of the need to secure the ETT tightly, which also limits the view 
of the breakdown site (Zaratkiewicz et al., 2012). Proper positioning of the ETT, 
along with special pads and dressings, may help alleviate skin damage (Fletcher, 
2012). Overall, pressure ulcers can cause pain and discomfort in patients, 
especially for children (Fletcher, 2012). If the skin damage is severe, it can leave 
permanent scars, which may require plastic surgery (Fujioka, Oka, Kitamura, & 
Yakabe, 2008). Figure 4 shows an example of a pediatric patient with a scar on 






Figure 4. Scar tissue on the upper lip. This image shows an example of a year 
old scar (indicated within the dotted white circle) left by a pressure ulcer from an 
oral ETT. (Figure downloaded from “Fujioka et al., 2008”).    
 
Specific to the pediatric cardiac patient is the oftentimes complicated 
postoperative or post-procedure course precluding early extubation, which 
makes the patient more susceptible to the complications of prolonged intubation 
and ventilation (Meissner, Scharf, & Schroth, 2008; Barker, Martino, Reichardt, 
Hickey, & Ralph-Edwards, 2009). While some patients may be weaned off the 
artificial ventilator within a few hours after surgery, other patients with severe 
illnesses may require several days, weeks, or longer to breathe on their own 
(American Thoracic Society, 2005). Dysphagia, which refers to problems with 
swallowing or oral feeding, is an example of a dangerous complication that may 
occur due to long-term endotracheal intubation and ventilation (Barker et al., 
2009; Skoretz, Flowers, & Martino, 2010). Dysphagia, according to Barker et al., 
is a fairly common complication especially for cardiac patients who are intubated 
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for longer than 48 hours postoperatively (Barker et al., 2009). Artificial airways, 
such as the ETT, have a risk of damaging the upper airway and laryngeal tissues 
and also causing infections to occur (Skoretz et al., 2010). This trauma can then 
lead to airway stenosis or swelling, and also negatively affect important breathing 
and swallowing reflexes (Skoretz et al., 2010). Just as the case for ETT 
manipulation, dysphagia also may be caused by incorrect ETT selection or 
placement. When patients experience dysphagia, they are unable to eat or drink 
properly and are at a high risk for malnutrition, dehydration, aspiration, poor 
weight gain, and slow recovery (Barker et al., 2009; Skoretz et al., 2010). In 
addition to dysphagia, prolonged intubation in the CICU may also cause pressure 
ulcers (as mentioned previously) to develop in superficial areas and internal 
respiratory tissues that are in contact with the endotracheal tube (Curley, 
Quigley, & Lin, 2003; McCord, McElvain, Sachdeva, Schwartz, & Jefferson, 
2004). 
 
Oral and Nasal Routes of Intubation 
 Although the route of intubation is the critical variable being analyzed for this 
ETT study, there is a relatively limited amount of research comparing oral vs. 
nasal routes for pediatric patients. Therefore, this preliminary study may have an 
important role in better understanding the indications and consequences of 
selecting one route of intubation over the other. While oral intubation is generally 
the easier and more common route, there are situations where nasal intubation is 
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indicated and more preferred (Holzapfel, 2003; Shindell, Windle, & Meyers, 
2012). The nasal ETT is usually used for patients undergoing any sort of dental, 
oral, or maxillofacial procedures, as well as patients with difficult oropharyngeal 
access (Shindell et al., 2012). The nasal ETT is also preferred by some 
anesthesiologists because it is easier to secure and more comfortable for the 
patient; it is not associated with tissue breakdown at the lips and tongue as with 
the oral ETT (Berry, 2007; Holzapfel, 2003) However, the nasal ETT may 
increase the risk of sinusitis and bacteremia by introducing nasal pathogens into 
the sinuses and upper airway, respectively (Holzapfel, 2003; Shindell et al., 
2012). Additionally, nasal intubation can cause epistaxis or bleeding in the nasal 
passageways (Shindell et al., 2012). These are important complications unique 
to the nasal ETT that should be considered on a case-by-case basis when 
deciding the route of intubation.  
 In terms of method and technique, the nasal ETT route involves a slightly 
different process that may be more difficult to learn and practice. First, the ETT 
should be properly lubricated to prevent abrasions; then it is passed through the 
left or right nare and into the nasopharynx (Berry, 2007; Shindell et al., 2012). 
Oftentimes the ETT needs to be adjusted and angled when met with resistance 
in the nasal airway (Shindell et al., 2012). Once the tube reaches the oropharynx, 
it can then be guided to the vocal cords using a laryngoscope and if necessary, a 
pair of magill forceps (Berry, 2007). A properly placed nasal ETT is depicted in 
figure 4.  
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Figure 5: Nasotracheal Intubation. This picture shows the correct placement of 
a cuffed nasal ETT along with the cuff location and pilot balloon as well. (Figure 
downloaded from “Nasotracheal Intubation, n.d.”) 
 
One particularly relevant study, by Spence & Barr, 1999, observed newborns 
in the neonatal intensive care unit and compared complication rates for nasally 
vs orally intubated patients. While complications may have been influenced by 
other factors such as tube size and depth, there was no significant difference 
between oral vs. nasal intubation in terms of effects on complications (Spence, & 
Barr, 1999). The incidence rates of incorrect ETT positioning, accidental 
extubation, re-intubation, local trauma, and airway infection were the main 
complications studied (Spence, & Barr, 1999). Despite this conclusion, Spence & 
Barr claimed that more research in the form of randomized controlled trials is 
necessary to determine whether oral or nasal ETT’s are more risky. Further 
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research is also necessary for pediatric patients across all age groups as well. 
Another study, by Depoix et al., focused specifically on adult patients undergoing 
cardiac surgery. The factors that Depoix et al. measured were: time needed to 
intubate, presence of bleeding or trauma and mechanical issues such as cuff 
rupture, incidence of bacteremia and sinusitis, comfort levels of the patient, and 
the incidence of dysphagia, dysphonia, and dyspnoea (Depoix, Malbezin, 
Videcoq, Hazebroucq, Barbier-Bohm, Gauzit, & Desmonts, 1987). Besides the 
fact that the nasal route took fairly longer than the oral route, there were no 
statistically significant differences in the two methods regarding the listed factors 
(Depoix et al., 1987).        
 When considering both studies by Depoix et al. and Spence & Barr, there is 
no conclusive data that favors one route of intubation over the other with regards 
to accidental extubation rates and infection rates (Holzapfel, 2003). However, 
neither study specifically examined the pediatric cardiac patient population. 
Therefore, further research - such as this preliminary study - may potentially 
reveal distinct advantages in selecting one route of intubation over another in the 
pediatric CICU setting.  
 
RACHS-1 Categories 
 Regarding the patient population involved in this study, one factor that may 
help identify risk groups for endotracheal tube complications is the type of 
cardiac procedure that the patient undergoes. Most of the patients that are 
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admitted to the CICU have one or multiple congenital heart diseases that are 
being treated. Furthermore, most of the patients involved in this study have gone 
through special surgical procedures designed to correct heart defects and 
problems. Although congenital heart defects are rare, they are one of the 
“leading causes of death” in children (Jenkins et al., 2002). Congenital heart 
defects are the “most common type of birth defect” and the most deadly type of 
defect for children under the age of one (A.D.A.M. Medical Encyclopedia, 2011). 
Some examples include: tetralogy of fallot, ebstein’s anomaly, atrial septal 
defect, patent ductus arteriosus, and coarctation of the aorta (A.D.A.M. Medical 
Encyclopedia, 2011). These defects may weaken the ability of the heart to 
properly pump oxygenated blood to the rest of the body and deoxygenated blood 
to the lungs. Therefore, congenital heart defects in pediatric patients are very 
serious conditions that affect cardiovascular, respiratory, and other organ 
functions. In particular, the severity of the illness and the associated procedure 
can dictate the pediatric patient’s outcome and vulnerability to undesired 
complications (Jenkins et al., 2002). One way to assess the difficulty and 
complexity of certain cardiac procedures is the RACHS-1 score (Jenkins et al., 
2002). Created by Jenkins et al. with the help of a panel of 11 medical experts 
across the nation, the RACHS-1 score system was specifically designed to 
assign mortality risk levels to surgeries addressing congenital heart disease 
(Jenkins et al., 2002). Some of the variables that were used to create the system 
include: in-hospital mortality, age, major noncardiac structural anomaly, and 
 21 
surgical procedure codes (Jenkins et al., 2002). Table 1 shows the 6 different risk 
categories and procedures that are included under each group. Instead of being 
used to predict the risk of death in individual cases, Jenkins et al. created this list 
to separate the broader pediatric cardiac patient population into distinct groups 
for clinical comparisons (Jenkins et al., 2002). Therefore, the RACHS-1 score 
system can be used to observe if patients in the higher risk categories are also 
associated with increased risk of ETT complications.  
Table 1: Individual procedures by risk category. The table below shows how 
each pediatric cardiac procedure is categorized based on risk levels, 1 being the 
lowest and 6 being the highest. (Table taken from “Jenkins et al., 2002”) 





Vasoactive Inotropic Scores 
 
Another important variable that can help determine risk groups is the 
inotropic support given to the pediatric patient. Inotropic drugs or agents affect 
the contractile strength of a patient’s heart (Texas Heart Institute Heart 
Information Center, 2013). Positive inotropic drugs increase the strength of the 
cardiac muscles, while negative inotropics drugs decrease the strength; patients 
with congenital heart disease usually require positive inotropic support in the OR 
and the CICU (Texas Heart Institute Heart Information Center, 2013). This 
support can be quantified into the “vasoactive-inotropic score”, which is then 
used as an approximate measure of how well a pediatric cardiac patient is doing 
postoperatively or post-procedure (Gaies, Gurney, Yen, Napoli, Gajarski, Ohye, 
Charpie, & Hirsch, 2010). The VIS takes into account the specific use of inotropic 
drugs - dopamine, dobutamine, epinephrine, milrinone, vasopressin, and 
norepinephrine – within a given timeframe (Gaies et al., 2010). Considering these 
drugs, a patient with a higher inotropic score may have a more severe illness and 
a greater risk of morbidity and mortality, than a patient with a low inotropic score 
(Gaies et al., 2010). While there are several different methods of calculating the 
VIS, table 2 shows the equation that Gaies et al. specifically created to compare 
inotropic support levels between individual patients. The main conclusion that 
Gaies et al. discovered was that the maximum VIS - within the first 48 hours 
postoperatively or post-procedure - can be used as a predictor for clinical 
outcomes in pediatric patients (Gaies et al., 2010). Therefore, a patient with a 
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higher VIS within the initial 48 hours may also have an increased risk for ETT 
complications compared to patients with a lower VIS. In particular, a patient with 
high inotropic support generally indicates low cardiac output (Gaies et al., 2010; 
Texas Heart Institute Heart Information Center, 2013). Low cardiac output is 
correlated with poor skin perfusion, which may then be associated with increased 
vulnerability to pressure ulcers (National Heart Lung and Blood Institute, 2012). 
With respect to this relationship, patients with higher VIS may have a greater risk 
to develop skin complications in particular from ETT’s.   
  
Table 2: VIS equation. This table depicts the inotropic score calculation. (Table 












The objective of this preliminary retrospective study is to establish 
incidence rates of specific postoperative endotracheal tube complications 
between cardiac patients who are intubated via the oral and nasal route, and to 
identify specific risk groups that could benefit from a change in practice or 
implementation of guidelines. Our hypothesis is that the nasal route of intubation 
may be associated with a lower incidence rate and risk of ETT complications 
than the oral route. In addition, the purpose of this study is to better understand 
the problems in current intubation methods and to identify potential changes in 
practice that may help reduce the incidence of ETT complications. 
While certain factors cannot be changed, others could be addressed with 
changes in practice or monitoring guidelines. The results of this study will 
therefore be used to identify specific groups of pediatric cardiac patients who are 
at high risk to develop complications and establish practice guidelines for the 
insertion and monitoring of endotracheal tubes. These could include 
recommendations regarding the insertion site or route of intubation, type of 
fixation, prophylactic repositioning, monitoring intervals, sedation regiments, etc. 
This preliminary study will collect data from 100 patients who were admitted to 
the Cardiac Intensive Care Unit at Boston Children’s Hospital from Oct 1st, 2010-
Sept 30th, 2011. This is only a sample group of the larger population of patients 






1. To determine the incidence of certain complications associated with 
indwelling endotracheal tubes in pediatric cardiac patients: pressure 
ulcers at insertion site, accidental extubations, need for tube 
repositioning, and dysphagia/feeding problems 
2. To discover differences in these complication rates between orally and 
nasally placed endotracheal tubes 
3. To identify subgroups of pediatric cardiac patients who are at 
increased risk for developing these complications 
Secondary Aims: 
4. To establish changes in current practice and guidelines aiming to 
reduce the incidence of these complications 





 The original scope of the study included all patients who were admitted to the 
CICU and received respiratory support with mechanical ventilation via an 
endotracheal tube during the fiscal years of 2010-2012 at BCH. This would’ve 
been from October 1st, 2009 through September 30th, 2012. However, the total 
number of patients was approximately 3600, and so a smaller (preliminary) 
retrospective case-control study was conducted using a sample group of 100 
patients admitted to the CICU from October 1st, 2010 to September 30th, 2011. 
We collected a large list of variables including: reason for admission, date of 
admission (starting date of respiratory support), RACHS-1 scores, vasoactive 
inotropic scores (maximum score within first 48hrs), type of mechanical 
ventilation, outcomes of treatment, age and weight of patients, gender of 
patients, reasons for use of mechanical ventilation, duration of ventilation, cuffed 
vs uncuffed ETT, oral vs nasal ETT, size of ETT, location where ETT was placed, 
start of first PO feeding, and hospital and CICU length of stay. We then noted the 
incidence of four specific types of ETT complications: dysphagia, unplanned 
extubation and/or multiple intubations, skin complications, and need for ETT 
adjustments. We looked for the incidence rate of any of these complications for 
orally intubated patients and then nasally intubated patients. We ran a Z-test and 
the Fisher’s Exact test to determine the difference of complication rates between 
the oral and nasal ETT groups and analyzed this difference in proportions for 
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statistical significance.  We then ran a multivariable regression, using selected 
covariates, to assess confounding factors that may have influenced the rate of 
complications. This retrospective case-control study was approved by the 
Institutional Review Board at Boston Children’s Hospital.  
 
Data Collection: 
 While there were about 3600 patients who were admitted to the CICU at 
Boston Children’s Hospital between Oct 1, 2009 and September 30, 2012, the 
sample group analyzed for this specific study included only 100 of these patients 
who were admitted between Oct 1, 2010 and September 30, 2011. The 
Respiratory Therapy team at Boston Children’s Hospital collected the initial 
ventilation data for each patient. Then, the Anesthesia Clinical Research Unit 
gathered the supplementary data through Powerchart on the hospital Cerner 
System. The Anesthesia Clinical Research unit will continue with the rest of the 
data collection beyond the sample group of this study. These additional data will 
be used for a follow-up or continuation study. The information on each patient 
was recorded onto a shared excel spreadsheet.       
 
Statistical Analysis: 
 Initially the Z test was used to compare the complication rates for the orally 
vs nasally intubated patient. Then the Fischer’s Exact test was performed to 
confirm the results from the Z test since the sample sizes for each group were 
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relatively small. A P value < 0.05 would be interpreted as a rejection of the null 
hypothesis and confirmation that the oral vs nasal groups have a statistically 
significant difference in complication rates. A multivariable regression was also 
performed to see if there were other factors involved in influencing or affecting 
complication rates overall. In order to determine which factors would be used in 
the regression (5 covariates), Mann-Whitney U and Fisher’s Exact tests were 
performed. Mann-Whitney U-tests were used for continuous variables when 
determining the p values between two groups; Fisher’s Exact tests were used for 
all other variables respectively.  
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RESULTS 
 This study was a retrospective case-control study and essentially a quality 
improvement chart review involving 100 patients who were admitted to the BCH 
CICU for postoperative or post-procedure care. Out of the 100 patients, 67 were 
orally intubated and 33 were nasally intubated. Looking at the general incidence 
of the four major ETT complications, 17 out of the 67 orally intubated patients 
experienced complications. Respectively, 6 out of the 33 nasally intubated 
patients had at least one of the four complications. 23 out of 100 patients 
experienced at least one of the four complications; the overall complication rate 
was 23%. A Z-test was used to calculate the difference between the complication 
rates of oral vs nasal ETT groups. The difference between the two independent 
proportions was calculated to be 0.0719 or approximately 7%. With respect to the 
95% confidence interval, the difference between the two proportions was 
between -0.1129 and 0.222 or -11% and 22%. This range alone reflects the 
uncertainty of the actual difference in complication rates. The z value equaled 
0.804 and the two-tailed analysis gave p values of 0.2107 and 0.4214. Both p 
values were significantly greater than 0.05 and therefore, the null hypothesis (no 
difference in oral vs nasal groups) was not rejected. This was further affirmed by 
observing the 95% confidence interval for each individual proportion. For the oral 
ETT group, the rate of complication ranged from 0.1649 or 16% to 0.3693 or 
37%. For the nasal ETT, the rate of complication ranged from 0.0861 or 9% to 
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0.3439 to 34%. There is a significant overlap in the two ranges that suggests that 
a significant difference cannot be determined. 
 The Fisher’s Exact test involved setting the two groups into a 2 by 2 
contingency table as shown in table 3. Once the table was prepared, the two-
tailed p value was calculated and assessed in the same manner as the z-test.  
 
Table 3. Fisher’s Exact test contingency table. This table splits up the two 




The p value was determined as 0.4621. Since 0.4621 > 0.05, the null hypothesis 
that the differences in complication rates are insignificant cannot be rejected. 
Thus, the Fisher’s Exact test further confirms that there is no statistically 
significant difference in complication rates between the oral and nasal ETT 
patients.  
 In order to run the multivariable regression, Mann-Whitney U-tests and 
Fisher’s Exact tests were performed to determine which variables would be used 
as covariates for the incidence of any of the four ETT complications. The 
following variables were tested in order to select five covariates for the 
 Complications No Complications Total 
Oral ETT 17 50 67 
Nasal ETT 6 27 33 
Total 23 77 100 
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regression analysis: age, weight, gender, total CMV hours, maximum inotropic 
score (within the first 48 hrs), RACHS-1 score, cuffed or uncuffed ETT, and route 
of intubation (oral vs nasal). The p values of each variable (with respect to the 
two study groups) as well as the descriptive statistics on the sample group data 
are shown in table 4. 
 
Table 4. Comparison of oral vs nasal ETT groups. This table lists the 
variables that may be potential confounders, while also looking at differences 
between orally and nasally intubated patients. Data for age, weight, RACHS-1 
score, CMV duration, inotropic scores are shown as the median followed by the 
interquartile range.  
*Statistically significant group difference in this variable. 
 
 
Comparison of Oral and Nasal Endotracheal Tube Groups 
 
Variable 
Oral ETT  
(n = 67) 
Nasal ETT  




   Male 








Age, years 3 (0.5 – 11.0) 0.4 (0.1 – 1.9) <0.001* 
Weight, kg 13.1 (5.4 – 36.3) 5.5 (3.6 – 10.4) <0.001* 
RACHS-1 score 2 (1 – 3) 2 (1 – 3) 0.42 
Total CMV, hours 17 (7 – 43) 42 (19 – 117) <0.001* 
Max. VIS 5 (0 – 10) 5 (0 – 10) 0.82 
Cuff 60 (90%) 27 (82%) 0.35 
    
Skin complications 7 (10%) 2 (6%) 0.71 
Dysphagia 4 (6%) 2 (6%) 1.00 
Unplanned 
extubation 
5 (8%) 2 (6%) 1.00 
ETT manipulation 11 (16%) 3 (9%) 0.38 
Any complication 17 (25%) 6 (18%) 0.46 
 
 
Mann-Whitney U-tests were used to calculate p values for age, weight, CMV 
hours, maximum inotropic scores, and RACHS-1 scores since they were all 
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continuous without normal distribution. Fisher’s Exact tests were used 
respectively for cuff, gender, and ETT complications since these variables were 
non-continuous. The p values represent the relationship between the values for 
oral and nasal ETT groups with respect to the listed variable in the same row.  
The three factors – age, weight, CMV hours - that have P values < 0.05 were 
selected for the multivariate regression as confounding factors, since they 
reflected the largest difference between the oral and nasal ETT groups. The last 
five rows in table 4 show the difference in complication rates between oral vs 
nasal groups for each individual complication as well as any of the four 
complications. None of the p values are less than 0.05; therefore, there is no 
statistically significant difference observed in the two rates for each or all of the 
complications. Nevertheless, ETT manipulation shows the greatest difference in 
rates between the two study groups. Table 5 looks at the same variables as table 
4 but with respect to two different groups: patients with complications and 
patients without any complications. Just as in table 4, the Mann-Whitney and 
Fisher’s Exact test were used for the variables in table 5. Table 5 shows whether 
certain factors may be correlated to the incidence of ETT complications. Lower p 
values indicate a potential predictor effect. The only p value that is actually < 0.05 
is listed for the maximum inotropic score. Therefore, this variable was included 






Table 5. Comparison of patients with and without complications. This table 
shows possible predictor variables of ETT complications. Data for age, weight, 
RACHS-1 score, CMV duration, inotropic scores are shown as median, followed 
by interquartile range.  
*Statistically significant group difference in this variable.  
 
The multivariate logistic regression technique was used to analyze the 
covariates selected for possible associations with a higher risk of ETT 
complications. The fifth covariate was chosen as the route of intubation (oral vs 
nasal) by default. The results of the regression revealed that only two of the five 
variables are statistically associated with the incidence of ETT complications. 
The first predictor variable is age - with a p value of 0.025 - where older patients 
are at a higher risk for complications. The second predictor variable is maximum 
inotropic score – with a p value of 0.009 – where higher scores are linked with a 
Comparison	  of	  Patients	  With	  and	  Without	  Complications	  
	  
Variable	  
Any	  Complication	  	  
(n	  =	  23)	  
No	  Complication	  	  




	  	  	  Male	  








Age,	  years	   3	  (0.2	  –	  11.0)	   1.2	  (0.3	  –	  5.0)	   0.42	  
Weight,	  kg	   12.8	  (3.6	  –	  47.8)	   9.2	  (4.5	  –	  19.4)	   0.34	  
RACHS-­‐1	  score	   3	  (1	  –	  3)	   2	  (1	  –	  3)	   0.31	  
Total	  CMV,	  hours	   39	  (8	  –	  120)	   19	  (8	  –	  56)	   0.18	  
Max.	  VIS	   8	  (0	  –	  20)	   5	  (0	  –	  10)	   	  	  0.04*	  
Cuff	   19	  (83%)	   68	  (88%)	   0.49	  
	   	   	   	  
Skin	  complications	   7	  (10%)	   2	  (6%)	   0.71	  
Dysphagia	   4	  (6%)	   2	  (6%)	   1.00	  
Unplanned	  
extubation	  
5	  (8%)	   2	  (6%)	   1.00	  
ETT	  manipulation	   11	  (16%)	   3	  (9%)	   0.38	  
Any	  complication	   17	  (25%)	   6	  (18%)	   0.46	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higher risk for complications. The other covariates - weight, CMV time, and route 
of intubation - showed p values of 0.92, 0.93, and 0.77, respectively. Tables 6 
and 7 represent the multivariate logistic regression results and the p values for 
each covariate.  
 
Table 6. Regression model for ETT complications. This table shows the 
results of the multivariate regression where the significance of the change (on the 
right column) can be interpreted as the p value with regards to whether a 
covariate strongly affects the outcome (complications).  
  
     
 Variable Model 
Log 
Likelihood 
Change in -2 
Log Likelihood 
df Sig. of the 
change 
Step 1 Oral vs Nasal ETT -46.473 0.088 1 0.767 
 Age (yr) -46.672 0.487 1 0.485 
 Weight (kg) -46.437 0.018 1 0.895 
 Total CMV (hrs) -46.433 0.009 1 0.923 
 Max VIS (48hr) -49.853 6.849 1 0.009 
Step 2 Oral vs Nasal ETT -46.477 0.088 1 0.767 
 Age (yr) -46.681 0.495 1 0.482 
 Weight (kg) -46.441 0.015 1 0.901 
 Max VIS (48hr) -49.897 6.928 1 0.008 
Step 3 Oral vs Nasal ETT -46.482 0.082 1 0.774 
 Age (yr) -48.906 4.930 1 0.026 
 Max VIS (48hr) -49.901 6.920 1 0.009 
Step 4 Age (yr) -48.979 4.994 1 0.025 
 Max VIS (48hr) -49.901 6.838 1 0.009 
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Table 7. Additional regression model for ETT complications. This table 
examines the covariates that were determined to be unassociated with the risk of 
complications based on the results from table 6. 
    
  
 Variable Score df Sig. of the change 
Step 2a Total CMV hrs 0.010 1 0.921 
 Overall statistics 0.010 1 0.921 
Step 3b Weight (kg) 0.016 1 0.901 
 Total CMV hrs 0.008 1 0.931 
 Overall statistics 0.025 2 0.987 
Step 4c Oral vs Nasal ETT 0.083 1 0.773 
 Weight (kg) 0.010 1 0.920 
 Total CMV hrs 0.008 1 0.931 
 Overall statistics 0.108 3 0.991 
 
          
For table 6, the regression can be broken down into four steps. Step 1 includes 
all five covariates to see which factors may be associated with the observed 
outcome. Step 2 removes the term or covariate that has the least association, 
CMV hours, and calculates the p values again for the other four covariates. Step 
3 and 4 repeat this process until the two remaining covariates, age and inotropic 
score, reveal significantly low p values. Table 7 takes the variables that were 
removed from table 6 and calculates separate p values. Step 4 from both tables 







 The original hypothesis that cardiac patients with nasal ETT’s have 
statistically lower complication rates compared to cardiac patients with oral ETT’s 
could not be proven to be true. The Fisher’s Exact test determined that the p 
value for the 2 X 2 contingency table (as previously noted) was 0.4621. This 
means that the 7% difference observed in complication rates can be interpreted 
as pure chance and not based on the characteristics of the two treatment groups.  
While the null hypothesis cannot be rejected, based on the preliminary p value, 
the multivariate logistic regression revealed other variables that are associated 
with the risk of ETT complications. Patients with older age and patients who 
undergo higher inotropic support (up to 48 hours postoperatively) are at a greater 
risk to develop at least one of the four major complications. As mentioned in the 
introduction, patients with higher inotropic support may be associated with poor 
skin perfusion and greater risk to develop pressure ulcers. As for age, older 
patients tend to be orally intubated, while children may be nasally intubated due 
to the increased comfort and decreased difficulty in securing the ETT. If the 
original hypothesis can be proven to be true, then the correlation between older 
age and increased complication rates can be validated via the route of intubation.   
Nevertheless, further research is necessary to determine how age and VIS are 
associated with risks of ETT complications.  
With regards to the first aim of this study, the overall incidence rate of ETT 
complications was discovered to be 23 out of 100 patients or 23%. While the oral 
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vs nasal group results may be inconclusive, the general incidence rate indicates 
that over 1 in 5 patients in the CICU experience at least one of the four major 
ETT complications. This is an alarmingly high proportion that needs to be 
addressed by changing guidelines and current practices of endotracheal 
intubation. When looking at individual complication rates, it seems that the most 
common complication is ETT manipulation. It also seems that the oral and nasal 
ETT groups show the greatest difference in rates within this particular 
complication. Therefore, the results of this study show that initial placement and 
proper securing of the ETT may be important in terms of lowering overall 
complication rates. Furthermore, there may be a greater risk for ETT 
displacement using the oral ETT compared to the nasal ETT (although the data 
is inconclusive due to the lack in power). The second most common complication 
is skin complication or breakdown. While the difference in proportions is only 4%, 
further research may potentially reveal a correlation in increased pressure ulcers 
and oral ETT use (as opposed to the nasal ETT). The third and fourth most 
common complications are unplanned extubation, and dysphagia, respectively; 
none of these reflect significant proportional differences in rates for the two 
treatment groups. 
Due to the relatively small sample size of patients, the results related to the 
second aim are preliminary at best. In order to find a clinically significant 
difference in complication rates between the orally intubated and nasally 
intubated patients, this study requires at least 80% power. This means that the 
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study should have at least 80% chance of correctly rejecting the null hypothesis 
and only 20% chance of not rejecting the null hypothesis when it is actually false 
(Sullivan, 2012). In other words, it is more likely that the null hypothesis is not 
rejected when it should be rejected, if the study achieves a smaller power 
(Sullivan, 2012). Since this study did not achieve the minimum desired power of 
80%, there is a small chance that the null hypothesis may actually be false – 
leading to the conclusion that the original hypothesis may actually be true. 
Therefore, while the preliminary results disprove the hypothesis, there needs to 
be further data collection and statistical analysis to confirm that the null 
hypothesis cannot be rejected. If this retrospective study were to be able to 
achieve 80% power, it would require at least 200 patients per treatment group 
(400+ total). This projected sample size and power would allow clinically relevant 
differences of rates in complications to be detected (as small as 10%). Smaller 
differences would require larger sample sizes, but for the purpose of this study, 
any difference smaller than 10% would not be clinically conclusive. Since the 
difference detected in this study was only 7% and since 80% power was not 
achieved, further research is necessary. 
The third aim was addressed through the multivariable regression, as stated 
before. The multivariate logistic regression identified two important factors, age 
and inotropic score, that may act as predictors for ETT complication. Therefore, it 
may be important to involve these factors in separate or additional studies to 
detect statistically significant differences across new treatment groups. In 
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particular, further research on VIS and the incidence of pressure ulcers may 
reveal an important connection.  While the regression ultimately excluded 
gender, weight, RACHS-1 score, CMV hours, oral vs nasal ETT, and cuffed vs 
uncuffed ETT, these variables should still be included in future studies that 
involve larger sample sizes since they may have clinical relevance in 
complications. In particular, the last three variables listed above should be 
included because they were selected for the regression through Mann-Whitney U 
tests and Fisher’s Exact tests. As mentioned in the introduction, cuffed and 
uncuffed ETT’s may have implications on all four types of complications since the 
cuffs may help secure the ETT but raise the risk of airway damage. Longer CMV 
hours may also increase the risk of skin breakdown and dysphagia, and oral vs 
nasal routes of intubation may differ in terms of securing the ETT and incidence 
of pressure ulcers.  
Prior to running the regression, the variables initially used as additional 
covariates – age, weight, gender, RACHS-1 score, total CMV hours, maximum 
inotropic score, cuff/uncuffed ETT - were chosen based on the likelihood of 
affecting complication rates. Other factors, such as location of intubation, length 
of hospital stay, ETT position, and ETT size were excluded because of the 
difficulty of analysis, lack of variation, or weak association with risks of 
complication. Reason for admission was also excluded because the RACHS-1 
score and inotropic score were more useful in terms of describing the severity of 
the patient’s heart disease and postoperative conditions of the patient. The type 
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of ventilator was also excluded because all the patients in this study received the 
same method of artificial ventilation. Although there are many different 
alternatives - such as assist-control ventilation, intermittent mandatory ventilation, 
pressure support breathing, and noninvasive ventilation – the most commonly 
used method of ventilation in this study was CMV or controlled (continuous) 
mandatory ventilation (Amitai, Sinert, Conrad, Talavera, Blackburn, Halamka, & 
Mosenifar, 2011). CMV delivers a certain volume of air consistently at set time 
intervals; this is most effective for patients who are unconscious and apneic due 
to general anesthesia (Amitai et al., 2011). 
 Regarding the fourth aim, it may be difficult to implement any changes in 
practice or intubation methods based on this preliminary study. When future 
studies with higher power are performed, we can implement better guidelines for 
choosing an oral or nasal ETT in order to reduce the risk of complications. If the 
oral ETT is proven to have a significantly greater complication rate than the nasal 
ETT, then we can shift towards using the nasal ETT especially for pediatric 
cardiac patients who are at high risk for complications. We can assess risk levels 
based on variables that are identified to be strongly associated to complications, 
such as age and VIS. Designing follow-up prospective studies on the same type 
of patients may allow us to determine whether implemented changes in practice 
can actually lower the incidence of ETT complications. 
 While the fifth aim also requires additional research, one of the questions that 
we can ask is: can we find a strong association between certain variables and 
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individual complications, instead of overall complications? Another question that 
we can ask is: does the use of a transesophageal echocardiogram influence the 
development of complications, especially dysphagia? 
        
Conclusions: 
 Our original hypothesis that the nasal route of intubation has a significantly 
lower risk and incidence rate of ETT complications compared to the oral route 
could not be proven to be correct. A follow-up study with a much larger sample 
size of patients may help prove our original hypothesis as long as it achieves at 
least 80% power. Conversely, it may actually disprove our hypothesis if the 
difference between complication rates for oral vs nasal ETT groups is proven to 
be statistically insignificant. The uncertainty of the results in this preliminary 
study, due to the small sample size, indicates the necessity for future studies to 
be performed. Additional research can also help reveal how patient age and 
maximum inotropic score may act as predictors for ETT complications.  
 A continuation of this retrospective study will be conducted using additional 
patients who were admitted to the CICU between October 1st, 2010 and 
September 30th, 2012. The results and conclusions taken from additional 
research can then be used to design prospective studies that involve changes in 
endotracheal intubation protocol and postoperative respiratory care for pediatric 
cardiac patients. 
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